Dr. Moritz Kircher

The Kircher lab at Memorial Sloan Kettering is developing novel nanoprobes for molecular imaging, image-guided therapy, and theranostics. Our ultimate goal is to develop a universal technology that allows determination of the total tumor burden in a patient before, during, and after treatment. This will allow detection of both the primary tumor, as well as metastases, both pre- and intraoperatively.